Successful treatment of recalcitrant palmoplantar psoriasis with etanercept

被引:0
作者
Weinberg, JM
机构
[1] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Dermatol, New York, NY 10025 USA
[2] Beth Israel Med Ctr, New York, NY 10003 USA
来源
CUTIS | 2003年 / 72卷 / 05期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Palmoplantar psoriasis is a disabling condition characterized by recurrent crops of sterile pustules with associated erythema, fissuring, and scaling. Genetic and environmental factors have been implicated in its etiology. Topical treatments are frequently ineffective. Other treatment options include systemic. retinoids, psoralen-UVA (PUVA), and a combination of, both. We report a case of successful treatment of recalcitrant palmoplantar psoriasis with etanercept in a 59-year-old woman unresponsive to other treatment modalities.
引用
收藏
页码:396 / 398
页数:3
相关论文
共 9 条
[1]  
Gottlieb AB, 2002, J INVEST DERMATOL, V119, P234
[2]   Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy [J].
Iyer, S ;
Yamauchi, P ;
Lowe, NJ .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (01) :118-121
[3]   Generalised pustular psoriasis induced by cyclosporin A withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept [J].
Kamarashev, J ;
Lor, P ;
Forster, A ;
Heinzerling, L ;
Burg, G ;
Nestle, FO .
DERMATOLOGY, 2002, 205 (02) :213-216
[4]   ACITRETIN AND ETRETINATE IN THE TREATMENT OF PALMOPLANTAR PUSTULOSIS - A DOUBLE-BLIND COMPARATIVE TRIAL [J].
LASSUS, A ;
GEIGER, JM .
BRITISH JOURNAL OF DERMATOLOGY, 1988, 119 (06) :755-759
[5]   A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TOPICAL PUVA IN PERSISTENT PALMOPLANTAR PUSTULOSIS [J].
LAYTON, AM ;
SHEEHANDARE, R ;
CUNLIFFE, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1991, 124 (06) :581-584
[6]  
LEONARDI C, 2003, INT INV DERM 2003 AP
[7]  
Marsland A M, 2001, Skin Therapy Lett, V6, P3
[8]  
MATSUNAMI E, 1990, Journal of Dermatology (Tokyo), V17, P92
[9]  
Weinberg JM, 2003, CUTIS, V71, P25